Author

M. Droghetti

OpenAlex ID: A5034229220

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection

2020 · G. Gandaglia, A. Martini, et al. · European Urology Open Science · 14

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection

2020 · S. Scuderi, G. Gandaglia, et al. · European Urology Open Science · 3

Role of local and/or metastasis-directed therapy in patients with hormone-sensitive M1a prostate cancer – a systematic review

2022 · H.A. De Barros, I Van Beurden, et al. · European Urology Open Science · 1

PDF

P0233 Cost-minimization of Hugo RAS vs Da Vinci Xi in robot-assisted radical prostatectomy: A detailed micro-costing analysis

2026 · P. Piazza, A. Mottaran, et al. · European Urology

V001 Augmented Reality PSMA-3D guided robotic Pelvic Lymph Node Dissection (PLND) in prostate cancer patients

2026 · L. Bianchi, R. Scarlatti, et al. · European Urology

Fusion PSMA targeted biopsy for detecting clinically significant prostate cancer in men with negative or equivocal MRI – A pilot single-center

2025 · M. Droghetti, L. Bianchi, et al. · European Urology Open Science

Impact of local treatment in a modern cohort of metastatic hormone sensitive prostate cancer at PSMA-PET according to PROMISE V2 Criteria

2025 · L. Bianchi, M. Droghetti, et al. · European Urology Open Science

PSMA-PET vs. conventional imaging for preoperative staging high-risk PCa patients underwent surgery for cN0M0 disease: an European Association of Urology-Young Academic Urologists Prostate Cancer Working Group multi-institutional study

2025 · M. Droghetti, L. Bianchi, et al. · European Urology Open Science

A0838 – Impact of learning curve in the transitional phase from DaVinci to HUGO RAS robotic platform: Focus on robotic radical prostatectomy in an experienced center

2025 · L. Bianchi, P. Piazza, et al. · European Urology

A0819 – PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an 'EMBARK-Like' cohort

2025 · M. Droghetti, V. Pirelli, et al. · European Urology

V023 – Robot-assisted single docking nephroureterectomy using Hugo RAS robotic platform: First European experience at a tertiary referral robotic center

2025 · A. Mottaran, R. Scarlatti, et al. · European Urology

P082 PSMA-PET/CT and PROMISE v2 criteria for staging high-risk prostate cancer: Impact on treatment selection and preliminary oncological outcomes

2024 · E. Balestrazzi, L. Bianchi, et al. · European Urology Open Science

P081 PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: Implications from an 'EMBARK-Like' cohort

2024 · M. Droghetti, V. Pirelli, et al. · European Urology Open Science

P170 3D virtual models for planning and guidance of PADUA≥8 renal masses: impact on pentafecta achievement after robot-assisted partial nephrectomy

2024 · L. Bianchi, A. Mottaran, et al. · European Urology Open Science

PE100 Preliminary single-surgeon experience in prostate and renal surgery with Hugo RAS at a robotic referral center

2024 · A. Mottaran, P. Piazza, et al. · European Urology Open Science

Robot-assisted pyeloplasty with direct pyelo-ureteral anastomosis for retrocaval ureter

2024 · A. Mottaran, R. Scarlatti, et al. · European Urology

Intense surveillance for patients treated with radical prostatectomy and adverse pathologic features: early results from “easy-1 (early salvage radiotherapy-1) protocol”

2023 · S. Tamburini, L. Bianchi, et al. · European Urology Open Science

Three-dimensional derived volumetric and morphologic parameters to predict complications after robotic partial nephrectomy in patients with renal cancer

2023 · A. Mottaran, P. Piazza, et al. · European Urology Open Science

3D-derived volumetric and morphologic parameters to predict complications after robotic partial nephrectomy in patients with renal cancer

2023 · L. Bianchi, B. Bortolani, et al. · European Urology

RARP nerve sparing with 3D model reconstruction and TilePro 3D augmented reality

2023 · R. Schiavina, C. Beretta, et al. · European Urology

PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?)

2023 · M. Droghetti, L. Bianchi, et al. · European Urology

The impact of a multidisciplinary team on treatment of patients with bladder cancer

2023 · F. Chessa, R. Schiavina, et al. · European Urology

PSMA-PET in high-risk prostate cancer patients suitable for radical treatments: Scenario of detection and clinical impact for staging setting

2023 · L. Bianchi, A. Pissavini, et al. · European Urology

The impact of 3D modeling in surgical planning and outcomes of partial nephrectomy

2022 · M. Droghetti, B. Bortolani, et al. · European Urology Open Science

Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

2022 · M. Droghetti, L. Bianchi, et al. · European Urology Open Science

Works count: 51

Citation count: 18

H-index: 2

I10-index: 1